In a 36-year-old male with a history of childhood non-Hodgkin lymphoma presenting with intermittent right-sided headache and right shin pain, what diagnostic studies should be ordered?

Immediate Imaging: PET-CT and MRI Brain/Spine with Contrast

Given this patient's childhood non-Hodgkin lymphoma history and concerning symptoms of headache and shin pain, you should order PET-CT for systemic evaluation and MRI brain/spine with contrast to rule out neurolymphomatosis and CNS involvement, as these symptoms raise concern for late relapse or secondary malignancy.

Clinical Reasoning

This 36-year-old man is 25 years out from childhood NHL, presenting with focal neurologic symptoms (right-sided headache) and bone pain (shin). While these could be benign, his cancer history mandates aggressive workup for several critical possibilities:

Primary Concerns to Rule Out:

1. Neurolymphomatosis (NL)

• The combination of headache and peripheral pain (shin) is a red flag for nerve infiltration by lymphoma 1
• NL commonly affects cranial nerves (causing headache) and peripheral nerves, often presenting with severe pain and asymmetric distribution 1
• This can occur as late relapse even decades after initial treatment 2

2. CNS Lymphoma Involvement

• Headache warrants evaluation for leptomeningeal disease or parenchymal masses 3
• MRI is superior to CT for detecting CNS involvement and leptomeningeal infiltration 3

3. Bone Involvement

• Shin pain could represent osseous lymphoma recurrence
• PET-CT has replaced bone marrow biopsy for detecting bone involvement in most cases 3

Recommended Diagnostic Algorithm

First-Line Studies (Order Immediately):

1. PET-CT (whole body)

   • This is the standard staging modality for FDG-avid lymphomas 3
   • Will detect systemic disease, bone involvement, and peripheral nerve involvement
   • Has high sensitivity for neurolymphomatosis 1
   • Can identify sites for potential biopsy if needed

2. MRI Brain and Spine with Contrast

   • Essential for evaluating CNS involvement (mass lesions, leptomeningeal disease) 3
   • Superior to CT for soft tissue detail and neural structures 4
   • Critical for detecting neurolymphomatosis affecting nerve roots and plexus 1

3. Complete Blood Count with Differential

   • Screen for cytopenias or circulating lymphoma cells

4. Comprehensive Metabolic Panel including LDH

   • Elevated LDH is associated with lymphoma and can indicate disease activity 5

Second-Line Studies (Based on Initial Findings):

• CSF analysis (cytology and flow cytometry) if MRI shows leptomeningeal enhancement 3
• Targeted biopsy of any accessible lesion identified on imaging for definitive diagnosis
• Plain radiographs of right shin if PET-CT shows focal uptake, though PET-CT alone may be sufficient

Critical Pitfalls to Avoid

1. Don't dismiss symptoms as benign in patients with lymphoma history—late relapses occur, and neurolymphomatosis is easily missed clinically 1, 2

2. Don't order CT alone—MRI is mandatory for adequate CNS and neural evaluation 3, 4

3. Don't delay imaging for extensive lab workup—the clinical presentation demands immediate anatomic and functional imaging 1

4. Avoid empiric corticosteroids before imaging and potential biopsy, as they can obscure lymphoma on imaging and histology 5

Why This Approach Prioritizes Mortality/Morbidity

Untreated CNS lymphoma and neurolymphomatosis carry significant mortality and irreversible neurologic morbidity. Early detection through PET-CT and MRI allows for timely treatment initiation, which is critical for preserving neurologic function and survival 1. The 18F-FDG PET/CT combined with MR neurography provides the highest diagnostic yield for neurolymphomatosis while avoiding the high risk of nerve damage from blind biopsy 1.